STAT3 inhibitor
Sep 20, 2018
Epic Sciences garners; Tvardi gets financing; Galera raises; Fund for cancer research
Epic Sciences garners USD 52 Million for blood tests in cancer patients Epic Sciences received USD 52 million to progress its suite of liquid biopsies that utilizes computer vision and machine learning to find circulating tumour cells while characterizing the immune response of the body at the same time. The Cancer...
Read More...
-Agonist.png "Toll-like Receptors Agonist")
